浏览全部资源
扫码关注微信
双硫仑/铜复合物通过Drp1去磷酸化和线粒体转位抑制肝癌细胞增殖并诱导细胞凋亡
Disulfiram/copper complex inhibits proliferation and induces apoptosis in hepatocellular carcinoma cells through dephosphorylation and mitochondrial translocation of Drp1
- 第三军医大学学报 2020年43卷第23期 页码：2302-2310
- 作者机构：
400038 重庆，陆军军医大学(第三军医大学)药学与检验医学系生药学与中药学教研室
- 作者简介：
[高宁，E-mail:gaoning59@163.com GAO Ning, E-mail:gaoning59@163.com
- 基金信息：国家自然科学基金面上项目(31571425)
DOI：10.16016/j.1000-5404.202007186
中图分类号： R735.7;R965.1;R979.19收稿：2020-07-23，
修回：2020-09-21，
纸质出版：2020-12-15
- 稿件说明：
移动端阅览
黎婕, 胡金娇, 姜秀星, 等. 双硫仑/铜复合物通过Drp1去磷酸化和线粒体转位抑制肝癌细胞增殖并诱导细胞凋亡[J]. 第三军医大学学报, 2020,43(23):2302-2310.
Jie LI, Jinjiao HU, Xiuxing JIANG, et al. Disulfiram/copper complex inhibits proliferation and induces apoptosis in hepatocellular carcinoma cells through dephosphorylation and mitochondrial translocation of Drp1[J]. Journal of Third Military Medical University, 2020, 43(23): 2302-2310.
黎婕, 胡金娇, 姜秀星, 等. 双硫仑/铜复合物通过Drp1去磷酸化和线粒体转位抑制肝癌细胞增殖并诱导细胞凋亡[J]. 第三军医大学学报, 2020,43(23):2302-2310. DOI： 10.16016/j.1000-5404.202007186.
Jie LI, Jinjiao HU, Xiuxing JIANG, et al. Disulfiram/copper complex inhibits proliferation and induces apoptosis in hepatocellular carcinoma cells through dephosphorylation and mitochondrial translocation of Drp1[J]. Journal of Third Military Medical University, 2020, 43(23): 2302-2310. DOI： 10.16016/j.1000-5404.202007186.
摘要
目的
2
研究双硫仑/铜复合物二乙基二硫代氨基甲酸铜对肝癌细胞增殖及凋亡的影响，并探讨其作用机制。
方法
2
用不同浓度(0、0.01、0.05、0.10、0.50、1.00、2.00 μmol/L)的CuET处理，CuET(2.00 μmol/L)作用不同时间(0、3、6、9、12、24 h)或Drp1线粒体转位的选择性抑制剂Mdivi-1(1.00 μmol/L)预处理肝癌细胞HepG2、SMMC-7721后，MTT实验检测细胞存活率，软琼脂克隆形成实验确定集落形成，流式细胞术分析细胞凋亡，激光共聚焦检测Drp1线粒体转位，Western blot检测细胞凋亡的相关蛋白cleaved-Caspase 9、cleaved-Caspase 3、cleaved-PARP1、细胞色素C(cytochrome C，cyto C)，以及线粒体分裂蛋白phospho-Drp1(S637)、phospho-Drp1(S616)和Drp1的表达。
结果
2
CuET对HepG2和SMMC-7721细胞增殖和集落形成的抑制作用呈剂量依赖性(
P
<
0.01)；对HepG2和SMMC-7721细胞凋亡诱导作用也有明显的剂量和时间依赖性(
P
<
0.01)；Western blot检测结果显示，CuET可导致Caspase 3和Caspase 9的裂解激活，PARP的降解激活以及cyto C从线粒体向细胞质的释放。CuET处理可导致Drp1(S637)去磷酸化和Drp1线粒体转位。细胞经Mdivi-1预处理后可明显阻断CuET诱导的Drp1线粒体转位、Caspase 3的裂解/激活、cyto C的释放以及细胞凋亡。
结论
2
双硫仑/铜复合物通过Drp1去磷酸化和线粒体转位抑制肝癌细胞增殖并诱导细胞发生凋亡。
Abstract
Objective
2
To determine the effects of disulfiram/copper complex
copper(Ⅱ) diethyldithiocarbamate (CuET) on the proliferation and apoptosis of hepatocellular carcinoma cells
and investigate the molecular mechanisms.
Methods
2
MTT assay was used to detect cell viability in the hepatocellular carcinoma HepG2 and SMMC-7721 cells treated with CuET at the concentrations of 0
0.01
0.05
0.1
0.5
1 or 2 μmol/L for 24 h. Then after the HepG2 and SMMC-7721 cells were treated with 2 μmol/L CuET for 0
3
6
9
12 or 24 h
MTT assay
soft agar assay and flow cytometry were used to determine cell viability
colony formation and cell apoptosis
respectively. And Western blotting was performed to detect the expression of apoptosis-related proteins
including cleaved-Caspase 9
cleaved-Caspase 3
cleaved-PARP1 and cytochrome C
and mitochondrial mitotic proteins
such as phospho-Drp1 (S637)
phospho-Drp1(S616)
and dynamin-related protein 1 (Drp1). Laser confocal scanning microscopy was carried out to observe the effect of 1 μmol/L Mdivi-1 pretreatment (a selective inhibitor of Drp1 mitochondrial translocation) for 2 h on the mitochondrial translocation of Drp1. Its effects on the apoptosis and expression levels of above proteins were also studied.
Results
2
Compared with the control cells (0 μmol/L)
CuET treatment showed inhibitory effects on the proliferation and colony formation
and inductive effect on the apoptosis in HepG2 and SMMC-7721 cells in dose- and time-dependent manners (all
P
<
0.01). Western blot assay indicated that CuET treatment led to cleavage/activation of Caspase 3 and Caspase 9
degradation of PARP
as well as release of cytochrome C from the mitochondria into the cytoplasm. CuET treatment also caused dephosphorylation and mitochondrial translocation of Drp1 (S637). Mdivi-1 pretreatment obviously blocked the mitochondrial translocation of Drp1
cleavage/activation of Caspase 3
release of cytochrome C
as well as cell apoptosis induced by CuET treatment.
Conclusion
2
CuET inhibits the proliferation and promotes apoptosis in hepatocellular carcinoma cells through dephosphorylation and mitochondrial translocation of Drp1.
关键词
Keywords
references
HIROKAWA F, HAYASHI M, ASAKUMA M, et al . Risk factors and patterns of early recurrence after curative hepatectomy for hepatocellular carcinoma[J ] . Surg Oncol, 2016, 25(1): 24-29. DOI:10.1016/j.suronc.2015.12.002.
BRAY F, FERLAY J, SOERJOMATARAM I, et al . Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J ] . CA Cancer J Clin, 2018, 68(6): 394-424. DOI:10.3322/caac.21492.
COLLINS F S. Mining for therapeutic gold[J]. Nat Rev Drug Discov, 2011, 10(6): 397. DOI:10.1038/nrd3461.
WRIGHT C, MOORE R D. Disulfiram treatment of alcoholism[J]. Am J Med, 1990, 88(6): 647-655. DOI:10.1016/0002-9343(90)90534-k.
CVEK B. Nonprofit drugs as the salvation of the world's healthcare systems: the case of Antabuse (disulfiram)[J]. Drug Discov Today, 2012, 17(9/10): 409-412. DOI:10.1016/j.drudis.2011.12.010.
ILJIN K, KETOLA K, VAINIO P, et al . High-throughput cell-based screening of 4910 known drugs and drug-like small molecules identifies disulfiram as an inhibitor of prostate cancer cell growth[J ] . Clin Cancer Res, 2009, 15(19): 6070-6078. DOI:10.1158/1078-0432.ccr-09-1035.
CHEN D, CUI Q C, YANG H, et al . Disulfiram, a clinically used anti-alcoholism drug and copper-binding agent, induces apoptotic cell death in breast cancer cultures and xenografts via inhibition of the proteasome activity[J ] . Cancer Res, 2006, 66(21): 10425-10433. DOI:10.1158/0008-5472.can-06-2126..
ZHA J, CHEN F L, DONG H J, et al . Disulfiram targeting lymphoid malignant cell lines via ROS-JNK activation as well as Nrf2 and NF-kB pathway inhibition[J ] . J Transl Med, 2014, 12(1): 1-9. DOI:10.1186/1479-5876-12-163..
SAFI R, NELSON E R, CHITNENI S K, et al . Copper signaling axis as a target for prostate cancer therapeutics[J ] . Cancer Res, 2014, 74(20): 5819-5831. DOI:10.1158/0008-5472.can-13-3527.
DUFOUR P, LANG J M, GIRON C, et al . Sodium dithiocarb as adjuvant immunotherapy for high risk breast cancer: a randomized study[J ] . Biotherapy, 1993, 6(1): 9-12. DOI:10.1007/bf01877380.
SKROTT Z, MISTRIK M, ANDERSEN K K, et al . Alcohol-abuse drug disulfiramtargets cancer via p97 segregase adaptor NPL4[J ] . Nature, 2017, 552(7684): 194-199. DOI:10.1038/nature25016..
ZHOU M, WANG H, ZENG X, et al . Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J ] . Lancet, 2019, 394(10204): 1145-1158. DOI:10.1016/s0140-6736(19)30427-1.
CHEN W Q, ZHENG R S, BAADE P D, et al . Cancer statistics in China, 2015[J ] . CA Cancer J Clin, 2016, 66(2): 115-132. DOI:10.3322/caac.21338.
WANG F S, FAN J G, ZHANG Z, et al . The global burden of liver disease: the major impact of China[J ] . Hepatology, 2014, 60(6): 2099-2108. DOI:10.1002/hep.27406.
FU J, WANG H. Precision diagnosis and treatment of liver cancer in China[J]. Cancer Lett, 2018, 412: 283-288. DOI:10.1016/j.canlet.2017.10.008.
VOGEL A, CERVANTES A, CHAU I, et al . Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J ] . Ann Oncol, 2018, 29: ⅳ238-ⅳ255. DOI:10.1093/annonc/mdy308.
European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma[J]. J Hepatol, 2018, 69(1): 182-236. DOI:10.1016/j.jhep.2018.03.019.
ESTAQUIER J, ARNOULT D. Inhibiting Drp1-mediated mitochondrial fission selectively prevents the release of cytochrome C during apoptosis[J]. Cell Death Differ, 2007, 14(6): 1086-1094. DOI:10.1038/sj.cdd.4402107.
BROOKS C, CHO S G, WANG C Y, et al . Fragmented mitochondria are sensitized to Bax insertion and activation during apoptosis[J ] . Am J Physiol-Cell Physiol, 2011, 300(3): C447-C455. DOI:10.1152/ajpcell.00402.2010.
WAI T, LANGER T. Mitochondrial dynamics and metabolic regulation[J]. Trends Endocrinol Metab, 2016, 27(2): 105-117. DOI:10.1016/j.tem.2015.12.001.
XU B, WANG S, LI R, et al . Disulfiram/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-κB and Nrf2[J ] . Cell Death Dis, 2017, 8(5): e2797. DOI:10.1038/cddis.2017.176..
SHAH O'BRIEN P, XI Y, MILLER J R, et al . Disulfiram (antabuse) activates ROS-dependent ER stress and apoptosis in oral cavity squamous cell carcinoma[J ] . J Clin Med, 2019, 8(5): 611. DOI:10.3390/jcm8050611.
KIM J Y, CHO Y, OH E, et al . Disulfiram targets cancer stem-like properties and the HER2/Akt signaling pathway in HER2-positive breast cancer[J ] . Cancer Lett, 2016, 379(1): 39-48. DOI:10.1016/j.canlet.2016.05.026.
CHOI S A, CHOI J W, WANG K C, et al . Disulfiram modulates stemness and metabolism of brain tumor initiating cells in atypical teratoid/rhabdoid tumors[J ] . Neuro-Oncol, 2015, 17(6): 810-821. DOI:10.1093/neuonc/nou305.
LOO T W. Blockage of drug resistance in vitro by disulfiram, a drug used to treat alcoholism[J ] . J Natl Cancer Inst, 2000, 92(11): 898-902. DOI:10.1093/jnci/92.11.898.
SONG W, TANG Z, SHEN N, et al . Combining disulfiram and poly(l-glutamic acid)-cisplatin conjugates for combating cisplatin resistance[J ] . J Control Release, 2016, 231: 94-102. DOI:10.1016/j.jconrel.2016.02.039.
KESHAMOUNI V G, MICHAILIDIS G, GRASSO C S, et al . Differential protein expression profiling by iTRAQ-2DLC-MS/MS of lung cancer cells undergoing epithelial-mesenchymal transition reveals a migratory/invasive phenotype[J ] . J Proteome Res, 2006, 5(5): 1143-1154. DOI:10.1021/pr050455t.
0
浏览量
0
下载量
0
CSCD
- 网络PDF下载
- Meta-XML下载
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
关联资源
相关文章
相关作者
相关机构
- 技术支持由北京北大方正电子有限公司提供 京ICP备09064830号-19
京公网安备11010802024621 - 本系统建议在Chrome、 IE9+ 以上版本浏览器阅读本站内容，360浏览器请切换至极速模式
- Cookies帮助我们提供服务并提供个性化体验。使用本网站，即表示您同意我们使用Cookies
